Grossman, Trudy H.
Boston University,
United States
2025 Rank: 82382
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Microbiology
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 1567 out of 217955 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 82382 | 95393 |
| Total Cites | 296 | 298 |
| H-index | 9 | 9 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 100 | 100 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 135 | 137 |
| Number of Single+First+Last Authored Papers | 27 | 27 |
| Total Cites to Single+First+Last Authored Papers | 155 | 157 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 267 | 269 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.11 |
| Self-Citation Percentage |
0.67%
|
|
Grossman, Trudy H.
None,
2024 Rank: 118878
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Microbiology
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 2492 out of 204759 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 118878 | 135599 |
| Total Cites | 249 | 250 |
| H-index | 7 | 7 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 84 | 84 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 108 | 109 |
| Number of Single+First+Last Authored Papers | 27 | 27 |
| Total Cites to Single+First+Last Authored Papers | 127 | 128 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 226 | 227 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.10 |
| Self-Citation Percentage |
0.40%
|
|
Grossman, Trudy H.
Azitra, Inc.,
United States
2023 Rank: 100956
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Microbiology
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 2306 out of 190396 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 100956 | 116439 |
| Total Cites | 273 | 275 |
| H-index | 7 | 7 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 85 | 85 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 111 | 112 |
| Number of Single+First+Last Authored Papers | 27 | 27 |
| Total Cites to Single+First+Last Authored Papers | 138 | 139 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 248 | 250 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.10 |
| Self-Citation Percentage |
0.73%
|
|
Grossman, Trudy H.
Melinta Therapeutics, Inc.,
United States
2022 Rank: 98817
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Microbiology
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 2313 out of 175943 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 98817 | 116120 |
| Total Cites | 250 | 257 |
| H-index | 8 | 8 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 64 | 64 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 96 | 96 |
| Number of Single+First+Last Authored Papers | 27 | 27 |
| Total Cites to Single+First+Last Authored Papers | 122 | 122 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 209 | 212 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.21 |
| Self-Citation Percentage |
2.72%
|
|
Grossman, Trudy H.
Melinta Therapeutics, Inc.,
United States
2021 Rank: 104684
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Microbiology
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 2343 out of 165244 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 104684 | 119157 |
| Total Cites | 393 | 408 |
| H-index | 10 | 10 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 85 | 85 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 139 | 142 |
| Number of Single+First+Last Authored Papers | 27 | 27 |
| Total Cites to Single+First+Last Authored Papers | 188 | 194 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 324 | 329 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.24 |
| Self-Citation Percentage |
3.68%
|
|
Grossman, Trudy H.
Tetraphase Pharmaceuticals,
United States
2020 Rank: 120182
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Microbiology
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 2518 out of 134369 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 120182 | 139775 |
| Total Cites | 288 | 296 |
| H-index | 9 | 9 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 30 | 30 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 93 | 95 |
| Number of Single+First+Last Authored Papers | 27 | 27 |
| Total Cites to Single+First+Last Authored Papers | 144 | 149 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 215 | 217 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.36 |
| Self-Citation Percentage |
2.70%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.